| [1] | Rubino F., Puhl R.M., Cummings D.E., et al. (2025). Definition and diagnostic criteria of clinical obesity. Lancet Diabetes Endocrinol. 13:221−262. DOI:10.1016/S2213-8587(24)00316-4 |
| [2] | West S., Scragg J., Aveyard P., et al. (2026). Weight regain after cessation of medication for weight management: Systematic review and meta-analysis. BMJ 392:e085304. DOI:10.1136/bmj-2024-085304 |
| [3] | Jensen S.B.K., Blond M.B., Sandsdal R.M., et al. (2024). Healthy weight loss maintenance with exercise, GLP-1 receptor agonist, or both combined followed by one year without treatment: A post-treatment analysis of a randomised placebo-controlled trial. EClinicalMedicine 69:102475. DOI:10.1016/j.eclinm.2024.102475 |
| [4] | Liu D., Chen Y., Li X., et al. (2026). Nucleotide metabolic rewiring enables NLRP3 inflammasome hyperactivation in obesity. Science 391:eadq9006. DOI:10.1126/science.adq9006 |
| [5] | Li W., Wang D., Chen H., et al. (2024). The relationship between psychological distress and weight maintenance in weight cycling: Mediating role of eating behavior. BMC Public Health. 24:894. DOI:10.1186/s12889-024-18404-7 |
| Wang M. and Chen W. (2026). The challenge of weight management: Looking beyond short-term solutions. The Innovation Nutrition 1:100011. https://doi.org/10.59717/j.xinn-nutri.2026.100011 |
To request copyright permission to republish or share portions of our works, please visit Copyright Clearance Center's (CCC) Marketplace website at marketplace.copyright.com.
A mechanism-informed clinical roadmap for refractory obesity management in China.